Robertson Stephens Wealth Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1767307
San Francisco, CA
Position in ALNY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$837,465
-$100,882 QoQ
Shares Held
2,782
-1.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#419
of 784 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Robertson Stephens Wealth Management, LLC holds $4,144,185 across 13 Biotechnology names. ALNY ranks #2 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
14,682 | $1,028,180 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,782 | $837,465 | |
| 3 | INCY |
Incyte Corp
|
6,672 | $756,337 | |
| 4 | CTMX |
CytomX Therapeutics, Inc.
|
96,000 | $360,000 | |
| 5 | CUE |
Cue Biopharma, Inc.
|
11,133 | $351,357 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
420 | $208,626 | |
| 7 | RLMD |
Relmada Therapeutics, Inc.
|
25,000 | $173,000 | |
| 8 | ACHV |
Achieve Life Sciences, Inc.
|
25,000 | $163,250 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $837,465 | 2,782 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $938,347 | 2,836 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,113,420 | 2,800 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||